News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
FDA
FDA Approves Genentech’s Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease
People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option.
November 6, 2017
·
2 min read
·
Alex Keown
Business
Layoffs in California: Amgen to Slash 200 R&D Jobs, Genentech to Cut 130
It’s not uncommon for companies to announce layoffs in the final months of the year.
November 6, 2017
·
2 min read
·
Mark Terry
Job Trends
Genentech Grows Manufacturing and Looks to the Future
October 11, 2017
·
2 min read
FDA
Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech’s $6 Billion Best-Seller
September 15, 2017
·
3 min read
Job Trends
Why 23andMe Quietly Recruited Genentech Scientists
September 12, 2017
·
1 min read
Drug Development
Genentech’s Macular Degeneration Candidate Flunks Phase III Study
September 8, 2017
·
2 min read
Policy
Bristol-Myers Squibb Slaps Lawsuit On Biotech Pioneer Genentech Over Cancer Immunotherapy Patents
July 27, 2017
·
1 min read
Drug Development
Genentech R&D Exec Reveals Alzheimer’s is Still A Priority
July 19, 2017
·
1 min read
Drug Development
Genentech’s Hemophilia Blockbuster Contender Hits Phase III Goals, But Questions Remain
June 26, 2017
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
December 22, 2025
·
16 min read
Press Releases
Genentech Announces Agreement With U.S. Government
December 22, 2025
·
2 min read
Press Releases
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
December 17, 2025
·
3 min read
Press Releases
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
December 17, 2025
·
6 min read
Press Releases
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
December 11, 2025
·
7 min read
Press Releases
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
December 10, 2025
·
13 min read
Press Releases
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
December 9, 2025
·
19 min read
Press Releases
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors
November 20, 2025
·
2 min read
Press Releases
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
November 19, 2025
·
8 min read
Press Releases
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
November 19, 2025
·
7 min read
